Tania Estapé^1,2* and Cosimo Pieri^1,3

¹Europa Uomo Board, Spain
²FEFOC Fundació, Barcelona, Spain
³Europa Uomo Italy, Milan, Italy

*Corresponding Author: Tania Estapé, Europa Uomo Board, FEFOC Fundació, Barcelona, Spain.

Received: July 22, 2022; Published: July 29, 2022

Abstract

Cancer is a disease feared for its relationship with death and suffering. Historically, the first cures are recent and the human being still associates the disease with a fatal end. Recent advances in cancer treatment imply cures and lengthening of life, but it is necessary to achieve quality of life. In prostate cancer, prostatectomy implies loss of erection and urinary incontinence, which alters the patient's life, self-esteem and sexuality. In order to reduce these unfortunate consequences, the therapeutic option called active surveillance has appeared. This option, paradoxically, consists of not treating but monitoring the tumor with follow-up and tests. It is indicated for low-risk tumors and opens the door to a radical change in the lives of those affected. However, our ancestors tell us that if it is cancer, it is best to remove it as soon as possible. This generates high levels of anxiety and family pressure. It is necessary to get patients to make the right decision so as not to suffer avoidable consequences.

Keywords: Cancer; Taboo Disease; Surveillance

References

1. Estapé Tania Iraida v Carrion., et al. “Exploring the Knowledge and Attitudes about Cancer of Older Adults in Barcelona, Spain”. Journal of Psychosocial Oncology Research and Practice1 (2020): e16.
2. Estapé Tania Jordi Estapé., et al. “Cancer Knowledge among Spanish Women Participating in Literacy Schemes”. Psycho-Oncology2 (2003): 194-197.
3. Estapé Madinabeitia Tania. Cáncer : cómo afrontar los tres días esenciales. Prefaced by Jordi Estapé Rodríguez, Editorial UOC, (2018).
4. Nguyen David-Dan., et al. “Sexual Function and Rehabilitation after Radiation Therapy for Prostate Cancer: A Review”. International Journal of Impotence Research4 (2021): 410-417.
5. Berger, Kathleen Stassen. The Developing Person through the Life Span (5" Ed.). (1994).
6. European Association of Urology. UAE - EANM - ESTRO - ESUR - ISUP - SIOG Guidelines on Prostate Cancer (2022).
7. Klotz Laurence. “Active Surveillance, Quality of Life, and Cancer-Related Anxiety”. European Urology1 (2013): 37-39.
8. Ruane‐McAteer Eimear., et al. “Investigating the Psychological Impact of Active Surveillance or Active Treatment in Newly Diagnosed Favorable‐risk Prostate Cancer Patients: A 9-month Longitudinal Study”. Psycho-Oncology8 (2019): 1743-1752.
9. Davison Barbara Joyce and Erin Breckon. “Factors Influencing Treatment Decision Making and Information Preferences of Prostate Cancer Patients on Active Surveillance”. Patient Education and Counseling3 (2012): 369-374.
10. Alvisi Maria Francesca., et al. “Supporting Patients With Untreated Prostate Cancer on Active Surveillance: What Causes an Increase in Anxiety During the First 10 Months?” Frontiers in Psychology 11 (2020).
11. Maheu Christine., et al. “Fear of Cancer Recurrence, Health Anxiety, Worry, and Uncertainty: A Scoping Review About Their Conceptualization and Measurement Within Breast Cancer Survivorship Research”. Frontiers in Psychology 12 (2021).

Citation

Citation: Tania Estapé and Cosimo Pieri. Active Surveillance in Prostate Cancer: When the Best Therapeutic Option is not to Treat". Acta Scientific Applied Physics 2.8 (2022): 28-31.

Copyright

Copyright: © 2022 Tania Estapé and Cosimo Pieri. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.